Optasia Medical, Ltd. Achieves ISO 9001 and ISO 13485 Certification
* Reuters is not responsible for the content in this press release.
CHEADLE, England and SUDBURY, Massachusetts, May 11 /PRNewswire/ --
Optasia Medical Ltd., a maker of model-based vision software for
musculoskeletal radiography has received certification for the successful
registration of our quality management system to both ISO 9001:2008 and ISO
13485:2003. The certification audit was performed by a representative of
Intertek in January 2009. The Intertek auditor examined all elements of the
Company's Quality Management System (QMS), including quality policy,
objectives, processes, record keeping, and also interviewed on-site staff.
Certification to ISO 9001:2008 and ISO 13485:2003 requires a commitment
to quality throughout the entire company. Policies and processes are
understood and followed at all levels and by all employees. Key processes in
the company are mapped out, controlled by monitoring, measurement and
analysis, and ensure that product quality objectives are met.
Optasia Medical's achievement of certification to these rigorous
standards demonstrates our on-going commitment to producing reliable and
innovative medical devices and illustrates our dedication to achieving the
highest standards of quality control.
About Optasia Medical
Optasia Medical makes software that facilitates the reading of x-rays for
the management of patients with musculoskeletal disease. Optasia's software
applications - SpineAnalyzer(TM) for osteoporosis, KneeAnalyzer(TM) for
osteoarthritis and HandAnalyzer(TM) for rheumatoid arthritis - are all based
on the Optasia(R) Platform which employs model-based vision technology to
detect, measure, classify and compare 2-dimensional medical images. Optasia's
software applications are used in clinical trials and by physicians to
identify and monitor patients who will benefit from treatment.
Contacts: UK: Alan Brett, +44-161-491-7860. US: Brian Kelly,
+1-978-457-1145
SOURCE Optasia Medical Limited
Contacts: UK: Alan Brett, +44-161- 491-7860. US: Brian Kelly, +1-978-457-1145
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters